146 related articles for article (PubMed ID: 33687713)
1. Human Blood Plasma Investigation Employing 2D UPLC-UDMS
Silva-Costa LC; Smith BJ; Carlson PT; Souza GHMF; Martins-de-Souza D
Methods Mol Biol; 2021; 2259():153-165. PubMed ID: 33687713
[TBL] [Abstract][Full Text] [Related]
2. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
[TBL] [Abstract][Full Text] [Related]
3. IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery.
Shi T; Zhou JY; Gritsenko MA; Hossain M; Camp DG; Smith RD; Qian WJ
Methods; 2012 Feb; 56(2):246-53. PubMed ID: 21925605
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of shotgun sequencing for proteomic analysis of human plasma using HPLC coupled with either ion trap or Fourier transform mass spectrometry.
Wu SL; Choudhary G; Ramström M; Bergquist J; Hancock WS
J Proteome Res; 2003; 2(4):383-93. PubMed ID: 12938928
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
[TBL] [Abstract][Full Text] [Related]
6. Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis.
Linke T; Doraiswamy S; Harrison EH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):273-81. PubMed ID: 17188586
[TBL] [Abstract][Full Text] [Related]
7. Abundant plasma protein depletion using ammonium sulfate precipitation and Protein A affinity chromatography.
Pringels L; Broeckx V; Boonen K; Landuyt B; Schoofs L
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():43-59. PubMed ID: 29758408
[TBL] [Abstract][Full Text] [Related]
8. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS.
Yang Z; Hancock WS; Chew TR; Bonilla L
Proteomics; 2005 Aug; 5(13):3353-66. PubMed ID: 16052617
[TBL] [Abstract][Full Text] [Related]
9. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
Zolotarjova N; Mrozinski P; Chen H; Martosella J
J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
[TBL] [Abstract][Full Text] [Related]
10. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.
Zhao YY; Lin RC
Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of rat plasma by two-dimensional liquid chromatography and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Linke T; Ross AC; Harrison EH
J Chromatogr A; 2006 Aug; 1123(2):160-9. PubMed ID: 16472533
[TBL] [Abstract][Full Text] [Related]
12. Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics.
Distler U; Kuharev J; Navarro P; Levin Y; Schild H; Tenzer S
Nat Methods; 2014 Feb; 11(2):167-70. PubMed ID: 24336358
[TBL] [Abstract][Full Text] [Related]
13. Limitation of immunoaffinity column for the removal of abundant proteins from plasma in quantitative plasma proteomics.
Ichibangase T; Moriya K; Koike K; Imai K
Biomed Chromatogr; 2009 May; 23(5):480-7. PubMed ID: 19039805
[TBL] [Abstract][Full Text] [Related]
14. Theoretical evaluation of peak capacity improvements by use of liquid chromatography combined with drift tube ion mobility-mass spectrometry.
Causon TJ; Hann S
J Chromatogr A; 2015 Oct; 1416():47-56. PubMed ID: 26372446
[TBL] [Abstract][Full Text] [Related]
15. Affinity prefractionation for MS-based plasma proteomics.
Pernemalm M; Lewensohn R; Lehtiö J
Proteomics; 2009 Mar; 9(6):1420-7. PubMed ID: 19235168
[TBL] [Abstract][Full Text] [Related]
16. Label-free proteomics of serum.
Govorukhina N; Horvatovich P; Bischoff R
Methods Mol Biol; 2008; 484():67-77. PubMed ID: 18592173
[TBL] [Abstract][Full Text] [Related]
17. Increased Depth and Breadth of Plasma Protein Quantitation via Two-Dimensional Liquid Chromatography/Multiple Reaction Monitoring-Mass Spectrometry with Labeled Peptide Standards.
Percy AJ; Yang J; Chambers AG; Borchers CH
Methods Mol Biol; 2016; 1410():1-21. PubMed ID: 26867735
[TBL] [Abstract][Full Text] [Related]
18. Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system.
Wu SL; Amato H; Biringer R; Choudhary G; Shieh P; Hancock WS
J Proteome Res; 2002; 1(5):459-65. PubMed ID: 12645918
[TBL] [Abstract][Full Text] [Related]
19. Sample preparation for detection of low abundance proteins in human plasma using ultra-high performance liquid chromatography coupled with highly accurate mass spectrometry.
Seong Y; Yoo YS; Akter H; Kang MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():272-280. PubMed ID: 28649027
[TBL] [Abstract][Full Text] [Related]
20. Assessing biological variation and protein processing in primary human leukocytes by automated multiplex stable isotope labeling coupled to 2 dimensional peptide separation.
Raijmakers R; Heck AJ; Mohammed S
Mol Biosyst; 2009 Sep; 5(9):992-1003. PubMed ID: 19668865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
